Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNPAT | O15228 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.45 |
| ▸ | C3AR1 | Q16581 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | NPY4R | P50391 | 2/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | NPY2R | P49146 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | FNTA | P49354 | 2/20 | 0.40 |
| ▸ | FNTB | P49356 | 2/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12028772 | 0.91 | GNPAT (0.61) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL17304353 | 0.91 | GNPAT (0.61) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL31503042 | 0.90 | GNPAT (0.60) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL19499056 | 0.89 | GNPAT (0.48) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL19499059 | 0.89 | GNPAT (0.48) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL6794052 | 0.88 | GNPAT (0.47) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL483091 | 0.88 | GNPAT (0.47) | GNPATNOD1C3AR1EPHX2NPY4R | |
| Hydrochloric Acid SCHEMBL15939612 | 0.87 | GNPAT (0.46) | GNPATNOD1C3AR1EPHX2NPY4R | |
| SCHEMBL17304356 | 0.87 | GNPAT (0.52) | GNPATNOD1EPHX2NPY4RNPY1R | |
| SCHEMBL1115964 | 0.87 | NOD1 (0.53) | GNPATNOD1C3AR1EPHX2NPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0724387-A4 | TREATMENT OF CHRONIC ANTI-INFLAMMATORY DISEASES BY ANGIOTENSION II RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1997-06-18 | — | — | EP | disclosed |
| EP-0724387-A1 | TREATMENT OF CHRONIC ANTI-INFLAMMATORY DISEASES BY ANGIOTENSION II RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-07 | — | — | EP | disclosed |
| WO-1995006410-A1 | TREATMENT OF CHRONIC INFLAMMATORY DISEASES BY ANGIOTENSION II RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-03-09 | — | — | WO | disclosed |